Janssen Research & Development, LLC (J&J PRD)
Time frame: 1 January 2023 - 31 December 2023Article ‘Count’ and ‘Share’ for Janssen Research & Development, LLC (J&J PRD) based on listed parameters only.
The articles listed below published by authors from Janssen Research & Development, LLC (J&J PRD), organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
Journal | Count | Share |
---|---|---|
Circulation |
2 | 0.29 |
Clinical Infectious Diseases |
2 | 0.29 |
European Urology |
1 | 0.57 |
Gastroenterology |
3 | 0.78 |
Gut |
1 | 0.16 |
JAMA Psychiatry |
1 | 0.06 |
Journal of Clinical Oncology |
2 | 0.50 |
Journal of the American Academy of Dermatology |
1 | 0.25 |
Journal of the American Society of Nephrology |
1 | 0.11 |
Kidney International |
1 | 0.07 |
Nature |
1 | 0.01 |
Nature Communications |
4 | 0.25 |
Nature Medicine |
3 | 0.44 |
Ophthalmology |
1 | 0.01 |
Proceedings of the National Academy of Sciences of the United States of America |
2 | 1.03 |
The Lancet Oncology |
2 | 0.58 |
The New England Journal of Medicine |
5 | 0.74 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.